These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36340715)

  • 21. Heterogeneity of ryanodine receptor dysfunction in a mouse model of catecholaminergic polymorphic ventricular tachycardia.
    Loaiza R; Benkusky NA; Powers PP; Hacker T; Noujaim S; Ackerman MJ; Jalife J; Valdivia HH
    Circ Res; 2013 Jan; 112(2):298-308. PubMed ID: 23152493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A delayed diagnosis of catecholaminergic polymorphic ventricular tachycardia with a mutant of RYR2 at c.7580T>G for 6 years in a 9-year-old child.
    Duan H; Lu Y; Yan S; Qiao L; Hua Y; Li Y; Zhou K; Wang C
    Medicine (Baltimore); 2018 Apr; 97(16):e0368. PubMed ID: 29668588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel heterozygous mutation in cardiac calsequestrin causes autosomal dominant catecholaminergic polymorphic ventricular tachycardia.
    Gray B; Bagnall RD; Lam L; Ingles J; Turner C; Haan E; Davis A; Yang PC; Clancy CE; Sy RW; Semsarian C
    Heart Rhythm; 2016 Aug; 13(8):1652-60. PubMed ID: 27157848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postpacing abnormal repolarization in catecholaminergic polymorphic ventricular tachycardia associated with a mutation in the cardiac ryanodine receptor gene.
    Nof E; Belhassen B; Arad M; Bhuiyan ZA; Antzelevitch C; Rosso R; Fogelman R; Luria D; El-Ani D; Mannens MM; Viskin S; Eldar M; Wilde AA; Glikson M
    Heart Rhythm; 2011 Oct; 8(10):1546-52. PubMed ID: 21699856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allele-Specific Silencing of Mutant mRNA Rescues Ultrastructural and Arrhythmic Phenotype in Mice Carriers of the R4496C Mutation in the Ryanodine Receptor Gene (
    Bongianino R; Denegri M; Mazzanti A; Lodola F; Vollero A; Boncompagni S; Fasciano S; Rizzo G; Mangione D; Barbaro S; Di Fonso A; Napolitano C; Auricchio A; Protasi F; Priori SG
    Circ Res; 2017 Aug; 121(5):525-536. PubMed ID: 28620067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenic mechanism of a catecholaminergic polymorphic ventricular tachycardia causing-mutation in cardiac calcium release channel RyR2.
    Xiong J; Liu X; Gong Y; Zhang P; Qiang S; Zhao Q; Guo R; Qian Y; Wang L; Zhu L; Wang R; Hao Z; Wen H; Zhang J; Tang K; Zang WF; Yuchi Z; Chen H; Chen SRW; Zheng W; Wang SQ; Xu YW; Liu Z
    J Mol Cell Cardiol; 2018 Apr; 117():26-35. PubMed ID: 29477366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arrhythmogenesis in a catecholaminergic polymorphic ventricular tachycardia mutation that depresses ryanodine receptor function.
    Zhao YT; Valdivia CR; Gurrola GB; Powers PP; Willis BC; Moss RL; Jalife J; Valdivia HH
    Proc Natl Acad Sci U S A; 2015 Mar; 112(13):E1669-77. PubMed ID: 25775566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism underlying catecholaminergic polymorphic ventricular tachycardia and approaches to therapy.
    Watanabe H; Knollmann BC
    J Electrocardiol; 2011; 44(6):650-5. PubMed ID: 21872879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New exome data question the pathogenicity of genetic variants previously associated with catecholaminergic polymorphic ventricular tachycardia.
    Jabbari J; Jabbari R; Nielsen MW; Holst AG; Nielsen JB; Haunsø S; Tfelt-Hansen J; Svendsen JH; Olesen MS
    Circ Cardiovasc Genet; 2013 Oct; 6(5):481-9. PubMed ID: 24025405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-ventricular, Clinical, and Functional Features of the RyR2(R420Q) Mutation Causing Catecholaminergic Polymorphic Ventricular Tachycardia.
    Domingo D; Neco P; Fernández-Pons E; Zissimopoulos S; Molina P; Olagüe J; Suárez-Mier MP; Lai FA; Gómez AM; Zorio E
    Rev Esp Cardiol (Engl Ed); 2015 May; 68(5):398-407. PubMed ID: 25440180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-coupled polymorphic ventricular tachycardia at rest linked to a novel ryanodine receptor (RyR2) mutation: leaky RyR2 channels under non-stress conditions.
    Cheung JW; Meli AC; Xie W; Mittal S; Reiken S; Wronska A; Xu L; Steinberg JS; Markowitz SM; Iwai S; Lacampagne A; Lerman BB; Marks AR
    Int J Cardiol; 2015 Feb; 180():228-36. PubMed ID: 25463374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postmortem genetic testing of the ryanodine receptor 2 (RYR2) gene in a cohort of sudden unexplained death cases.
    Larsen MK; Berge KE; Leren TP; Nissen PH; Hansen J; Kristensen IB; Banner J; Jensen HK
    Int J Legal Med; 2013 Jan; 127(1):139-44. PubMed ID: 22222782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Yield of the
    Kapplinger JD; Pundi KN; Larson NB; Callis TE; Tester DJ; Bikker H; Wilde AAM; Ackerman MJ
    Circ Genom Precis Med; 2018 Feb; 11(2):e001424. PubMed ID: 29453246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exon 3 deletion of RYR2 encoding cardiac ryanodine receptor is associated with left ventricular non-compaction.
    Ohno S; Omura M; Kawamura M; Kimura H; Itoh H; Makiyama T; Ushinohama H; Makita N; Horie M
    Europace; 2014 Nov; 16(11):1646-54. PubMed ID: 24394973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inherited catecholaminergic polymorphic ventricular tachycardia due to RYR2 mutation.
    Watanabe T; Ohno S; Shirai M; Endoh A; Hongo T; Ueta I; Yoshimoto J
    Pediatr Int; 2016 Jun; 58(6):512-515. PubMed ID: 27225049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EL20, a potent antiarrhythmic compound, selectively inhibits calmodulin-deficient ryanodine receptor type 2.
    Klipp RC; Li N; Wang Q; Word TA; Sibrian-Vazquez M; Strongin RM; Wehrens XHT; Abramson JJ
    Heart Rhythm; 2018 Apr; 15(4):578-586. PubMed ID: 29248564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium leak through ryanodine receptors leads to atrial fibrillation in 3 mouse models of catecholaminergic polymorphic ventricular tachycardia.
    Shan J; Xie W; Betzenhauser M; Reiken S; Chen BX; Wronska A; Marks AR
    Circ Res; 2012 Aug; 111(6):708-17. PubMed ID: 22828895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender Differences in the Inheritance Mode of RYR2 Mutations in Catecholaminergic Polymorphic Ventricular Tachycardia Patients.
    Ohno S; Hasegawa K; Horie M
    PLoS One; 2015; 10(6):e0131517. PubMed ID: 26114861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The V2475F CPVT1 mutation yields distinct RyR2 channel populations that differ in their responses to cytosolic Ca
    Wilson AD; Hu J; Sigalas C; Venturi E; Valdivia HH; Valdivia CR; Lei M; Musgaard M; Sitsapesan R
    J Physiol; 2021 Dec; 599(23):5179-5201. PubMed ID: 34676560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing.
    Tester DJ; Kopplin LJ; Will ML; Ackerman MJ
    Heart Rhythm; 2005 Oct; 2(10):1099-105. PubMed ID: 16188589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.